.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
US Department of Justice
Medtronic
Chinese Patent Office
Queensland Health
Mallinckrodt
Harvard Business School
Colorcon
Citi
Teva

Generated: November 18, 2017

DrugPatentWatch Database Preview

Isoflurane - Generic Drug Details

« Back to Dashboard

What are the generic sources for isoflurane and what is the scope of isoflurane freedom to operate?

Isoflurane
is the generic ingredient in two branded drugs marketed by Piramal Ent, Piramal Critical, Baxter Hlthcare, Halocarbon Prods, Watson Labs Inc, and Hospira, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for isoflurane. Three suppliers are listed for this compound.

Pharmacology for isoflurane

Drug ClassGeneral Anesthetic
Physiological EffectGeneral Anesthesia

Medical Subject Heading (MeSH) Categories for isoflurane

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Piramal Critical
ISOFLURANE
isoflurane
LIQUID;INHALATION074416-001Sep 30, 1994ANRXNoNo► Subscribe► Subscribe► Subscribe
Hospira
ISOFLURANE
isoflurane
LIQUID;INHALATION074097-001Jan 25, 1993ANRXNoNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
FORANE
isoflurane
LIQUID;INHALATION017624-001Approved Prior to Jan 1, 1982ANRXYesYes► Subscribe► Subscribe► Subscribe
Halocarbon Prods
ISOFLURANE
isoflurane
LIQUID;INHALATION075225-001Oct 20, 1999ANRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Inc
ISOFLURANE
isoflurane
LIQUID;INHALATION074393-001May 12, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Piramal Ent
ISOFLURANE
isoflurane
LIQUID;INHALATION074502-001Jun 27, 1995ANRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: isoflurane

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare
FORANE
isoflurane
LIQUID;INHALATION017624-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Baxter Hlthcare
FORANE
isoflurane
LIQUID;INHALATION017624-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
UBS
AstraZeneca
Accenture
US Department of Justice
Merck
Medtronic
Chinese Patent Office
Fuji
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot